(Total Views: 584)
Posted On: 08/18/2020 9:02:55 PM
Post# of 148899
Re: ClosetInvestor #50383
Patterson in YouTube with Dr Yo addresses RANTES expression on a range of tumor types. His assay is on a 300 pt scale. Prostate was 180 I believe (under 200 anyway). Bladder and urethral were 300. Seems as though leronlimab will be an instantaneous revolution in those.
I cannot recall pancreatic. I believe colorectal high as well, but not certain.
Not that other cancers are unimportant, but pancreatic and colorectal, with their high rates of occult progression until advanced metastates are at the top of my wish list with tnbc.
EUA/OWS cannot come quickly enough so that we can overcome Covid and save those dying from “normal” but heart wrenching disease.
There is no conceivable way that big federal players are unaware of leronlimab now. Other once promising therapeutics fallen to the wayside and recognition that a vaccine is not guaranteed and certainly not imminent.
I cannot recall pancreatic. I believe colorectal high as well, but not certain.
Not that other cancers are unimportant, but pancreatic and colorectal, with their high rates of occult progression until advanced metastates are at the top of my wish list with tnbc.
EUA/OWS cannot come quickly enough so that we can overcome Covid and save those dying from “normal” but heart wrenching disease.
There is no conceivable way that big federal players are unaware of leronlimab now. Other once promising therapeutics fallen to the wayside and recognition that a vaccine is not guaranteed and certainly not imminent.
(1)
(0)Scroll down for more posts ▼
